Company Overview of APT Pharmaceuticals, Inc.
Key Executives for APT Pharmaceuticals, Inc.
|Howard V. Raff Ph.D.||1 Relationships||Chief Operating Officer||65|
|Susan E. Barrowcliffe BSc||No Relationships||Global Head of Regulatory Affairs and Executive Vice President of Development Europe||58|
|Ralph W. Niven Ph.D., M.R, Pharm.S||9 Relationships||Chief Technology Officer||56|
|Gregory J. Baigent||No Relationships||Vice President of Pulmonary Transplant Program||--|
|Janice Lee||No Relationships||Senior Director of Project Management||--|
APT Pharmaceuticals, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Fred M. Schwarzer J.D.||25 Relationships||Amaranth Medical, Inc.||--|
|Albert Cha M.D., Ph.D., MS||37 Relationships||Vivo Capital, LLC||44|
|David E. Kroin||14 Relationships||Great Point Partners, LLC||41|
|Paul J. Sekhri||196 Relationships||Lycera Corp.||58|
|Nina S. Kjellson||76 Relationships||Canaan Partners||41|
APT Pharmaceuticals, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|There is no committee data available.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.